SlideShare a Scribd company logo
1 of 58
Download to read offline
Integration of Metabolism
Diabetes mellitus
Mulungushi University
School of Medicine and Health Sciences
Bachelor of Science in program
Biochemistry BMB 230
1
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
Dr. Masenga SK
To cover
•Metabolic effects of insulin and glucagon
•The feed/fast cycle
•Diabetes mellitus
•The Biochemistry of Diabetes Mellitus
•Forms of diabetes.
•Molecular aspects of glucose transport.
•Principles of treatment
•Obesity
2
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
Principals
• An adult human weighing 70 kg requires about 10–12 MJ
(2400–2900 kcal) from metabolic fuels each day.
• This requirement is met from
• carbohydrates (40–60%),
• lipids (mainly triacylglycerol, 30–40%),
• protein (10–15%),
• depending on whether the subject is in the fed or starving state and on
the intensity of physical work.
• When intake of fuels is consistently greater than energy
expenditure → storage fat → obesity
• When intake of fuels is consistently lesser than energy
expenditure → high turnover → emaciation and death.
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
3
Integrated metabolism
• Fed state: Glucose available → fuel for tissues
• Starvation : glucose spared for use by the CNS (which is largely
dependent on glucose) and the erythrocytes (which are wholly
reliant on glucose)
• Other tissues can utilize alternative fuels such as fatty acids and ketone
bodies
• As glycogen reserves become depleted, so amino acids arising from
protein turnover and glycerol arising from lipolysis are used for
gluconeogenesis.
• Insulin and Glucagon regulate
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
4
Glucagon and Insulin
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
5
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
6
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
7
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
8
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
9
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
10
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
11
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
12
DIABETES MELLITUS
DIABETES MELLITUS
•Definition
•Is actually a group of metabolic diseases
characterized by hyperglycemia resulting from
defects in insulin secretion1, insulin action2, or both3.
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
13
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
14
Diabetes Mellitus classification
•Therefore, the ADA/World Health
Organization (WHO) guidelines
recommend the following categories of
diabetes:
•Type 1 diabetes
•Type 2 diabetes
•Other specific types of diabetes;
MODY(Maturity onset diabetes of the
young)
•Gestational diabetes mellitus (GDM)
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
15
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
16
Classical symptoms
Classical Signs and symptoms:
•Polydipsia (Excessive Thirst)
•Polyphagia (Increased Food Intake)
•Polyuria (Excessive Urine Production)
•Rapid Weight Loss**
•Xerostomia (Dry Mouth)
•Hyperventilation
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
17
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
18
Pathophysiology
Clue to understanding the classical features
Type 1 diabetes
•result of cellular-mediated autoimmune destruction
of the cells of the pancreas, causing an absolute
deficiency of insulin secretion.
•constitutes only 10% to 20% of all cases of diabetes and
•This disease is usually initiated by
an environmental factor or
infection (usually a virus) in
individuals With a genetic
predisposition
commonly occurs in childhood
and adolescence.
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
19
•Characterized by :
•abrupt onset, insulin dependence,
hyperglycaemia, hyperosmolarity, low
pH(acidosis), ketonuria and ketonemia
•85% to 90% of individuals with fasting
hyperglycemia have 1 or more of these markers:
1. Islet cell autoantibodies,
2. Insulin autoantibodies,
3. glutamic acid decarboxylase autoantibodies,
4. tyrosine phosphatase IA-2 and IA-2B
autoantibodies.
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
20
Antibodies in T1DM
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
21
•Glutamic acid decarboxylase 65 (GAD)
•Protein tyrosine phosphatase islet
antigen-2 (IA2)
•Insulin.
•Zinc transporter 8 (ZnT8)
•Rationale For Diabetic Keto Acidosis
•In type 1, there is an absence of insulin with an excess of
glucagon. This permits gluconeogenesis and lipolysis to
occur.
•Patient’s lab profile presents with ketoacidosis tend to reflect
dehydration, electrolyte disturbances and acidosis.
•Acetoacetate, ᵝ-hydroxybutyrate and acetone are produced
from the oxidation of fatty acids.
• ketone bodies contribute to the acidosis.
•Lactate, fatty acids, and other organic acids can also
contribute to a lesser degree.
complications
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
22
•Bicarbonate and total carbon dioxide are usually decreased
due to Kussmaul respiration (deep respirations). This is a
compensatory mechanism to blow off carbon dioxide and
remove hydrogen ions in the process.
•The anion gap in this acidosis can exceed 16 mmol/L.
Serum osmolarity is high as a result of hyperglycemia;
•sodium concentrations tend to be lower (hyponatremia) due
in part to losses (polyuria) and in part to a shift of water
from cells because of the hyperglycemia.
•Grossly elevated triglycerides will displace plasma volume
and give the appearance of decreased electrolytes
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
23
Type 1 Diabetes Mellitus
•The individual will be hyperglycemic, which can be severe.
• Glucosuria can also occur after the renal tubular transporter
system for glucose becomes saturated. (at plasma glucose
concentration ≥180 mg/dL (10mmol/l) in an individual with
normal renal function and urine output ).
• As hepatic glucose overproduction continues, the plasma
glucose concentration reaches a plateau around 300 to 500
mg/dL (17–28 mmol/L). Provided renal output is
maintained, glucose excretion will match the overproduction ,
causing the plateau.
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
25
•Hyperkalemia is almost always present as a result
of the displacement of potassium from cells in
acidosis. This is somewhat misleading because the
patient’s total body potassium is usually
decreased.
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
26
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
27
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
28
Type 2 Diabetes Mellitus
Clinical Biochemistry
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
29
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
30
Pathophysiology
Clue to understanding the classical features
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
33
Insulin resistance
•Defined as the failure of target tissue to respond
normally to insulin
•Leads to :
• decreased uptake of glucose in muscle
• Reduced glycolysis
• Fatty acid oxidation in the liver
• Inability to suppress hepatic gluconeogenesis
• FATTY ACID EFFLUX out of adipose tissue
due to hormone sensitive lipoprotein lipase
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
34
ß-cell dysfunction
•Due to prolonged insulin resistance & eventually
hyperglycermia. Molecular mechanisms underlying ß-cell
dysfunction in type 2 diabetes are multifactorial & overlap
in many instances with those implicated in insulin
resistance.
•hence the excess NEFA & attenuated(reduced) insulin
signaling (“lipotoxicity”) predispose to both insulin
resistance & ß-cell failure.
•Amyloid replacement of islets is a characteristic finding in
individuals with long standing type 2 diabetes & is present
in more than 90% of diabetic islets examined.
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
35
•In type 2, insulin is present, as is (at times)
hyperinsulinemia; therefore, glucagon is attenuated
(lowered/reduced) → Weight gain (lipogenesis)
•Fatty acid oxidation is inhibited in type 2. This
causes fatty acids to be incorporated into
triglycerides for release as very low density
lipoproteins (VLDL).
•This might predispose a patient to acute
pancreatitis, development of eruptive xanthomata
(cholesterol deposits) and atherosclerosis.
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
36
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
37
Pathophysiology
Underlying Long term complications
PATHOPHYSIOLOGY CHAGES THAT
EXPLAIN THE LONG TERM COMPLICATIONS
OF DIABETES.
•The molecular pathogenesis of chronic diabetes
complications-
1. Excessive reactive oxygen species production
2. Formation of advanced glycosylation end (AGE)
products
3. Sorbitol production via the aldose reductase
pathway
4. Protein kinase c activation
Mnemonic = RASP
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
38
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
39
Long term
Complications of T2DM
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
40
Macrovascular complications (coronary artery
disease, peripheral arterial disease, and stroke)
Microvascular
complications (diabetic
nephropathy, neuropat
hy, and retinopathy)
Short-term complications include:
•Hypoglycaemia
•Diabetic ketoacidosis (DKA),
•Hyperosmolar hyperglycaemic state (HHS).
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
41
Infections
• Leukocyte function is compromised and immune responses
are blunted. hyperglycaemia effects in infections:
• Chemo taxis reduced
• Inhibits leukocyte rolling & adherence & phagocytosis
• reduces macrophage activation
• Reduces activation of the complement activation (C5a) therefore
reducing the Mac pathway (membrane attack complex) that lyses
bacteria
• Urinary tract infections are problematic
• Diabetes may develop fatal fungal infection - mucormycosis
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
42
Chemotaxis
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
43
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
44
Diagnosis
LABORATORY FINDINGS IN HYPERGLYCEMIA
1. Increased glucose in plasma and urine
2. Increased urine specific gravity
3. Increased serum and urine osmolality
4. Ketones in serum and urine (ketonemia and
ketonuria)
5. Decreased blood and urine pH (acidosis)
6. Electrolyte imbalance
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
45
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
46
Fasting blood glucose
• The FPG test is used to detect diabetes and prediabetes
• Fasting plasma glucose = 7.0 mmol/L
• Impaired fasting glucose = 5.6 to 6.9 mmol/L
• most common test used for diagnosing diabetes
• more convenient and less expensive.
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
47
Random blood glucose
• Symptoms of diabetes (polyuria, polydipsia, unexplained weight loss,
fatigue, blurred vision, polypagia, and sores that do not heal).
• Random blood glucose concentration >11.1 mmol/L .
• A repeat test can be done for confirmation
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
48
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
49
Oral Glucose Tolerance Test
• The OGTT can be used to diagnose diabetes, prediabetes, and gestational
diabetes.
• 2-hr postload glucose >11.1 mmol/L during an oral glucose tolerance test
(OGTT) is diabetes
• identifies more patients as having diabetes than the fasting plasma glucose
test,
• greater expense and complexity and lower reproducibility
• Rarely used
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
50
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
51
Glycated Hemoglobin - HbA1C
• Reflects the average blood glucose levels over the past 3 months
and does not show daily fluctuations.
• Reported as a percentage with threshold level of 6.5%.
• It does not require fasting and can be performed at any time of
the day.
• Hemoglobinopathies and conditions of altered red-cell turnover
can give unreliable results
• Racial and ethnic differences in glycated hemoglobin levels have
been reported for given ambient glucose levels.
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
52
Criteria for the Testing and Diagnosis of
Gestational Diabetes Mellitus
• Only high-risk patients should be screened for GDM.:
• age older than 25 years,
• overweight, strong family history of diabetes,
• history of abnormal glucose metabolism,
• history of a poor obstetric outcome,
• presence of glycosuria,
• diagnosis of PCOS, or a member of an ethnic/racial group
with a high prevalence of diabetes (e.g., Hispanic American,
Native American, Asian American, African American, Pacific
Islander).
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
53
Criteria for the Testing and Diagnosis of
Gestational Diabetes Mellitus
• The first step in screening for gestational diabetes
should be performance of fasting plasma glucose (as indicated
earlier) with a confirmation test if needed for diagnosis.
• In the absence of a positive confirmation, evaluation for
gestational diabetes in women with average or high-risk
characteristics should follow one of two approaches.:
• The one-step approach would be the im-mediate
performance of a 3-hour OGTT without prior screening.
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
54
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
55
Risk factors
Risk factors
• BMI
• Family history
• Age
• Physical activity
• Sedentary lifestyle
• Diet
• Existing NCDs
• Drugs
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
56
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences
57
reference
• Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell
VW, Weil PA; Harper’s illustrated Biochemistry, 28th edition;
http://www.accessmedicine.com
58
25-Jan-22
Mulungushi University School of Medicine and Health
Sciences

More Related Content

Similar to Diabetes mellitus both type 1 and 2 it's causes

Case study - DM 2, CKD 4
Case study - DM 2, CKD 4Case study - DM 2, CKD 4
Case study - DM 2, CKD 4
Reynel Dan
 
Bmj.h5660.full
Bmj.h5660.fullBmj.h5660.full
Bmj.h5660.full
sekarkt
 
Bmj.h5660.full
Bmj.h5660.fullBmj.h5660.full
Bmj.h5660.full
sekarkt
 
Diabetes melitus by dr aftab ahmed
Diabetes melitus by dr aftab ahmedDiabetes melitus by dr aftab ahmed
Diabetes melitus by dr aftab ahmed
aaiman46
 

Similar to Diabetes mellitus both type 1 and 2 it's causes (20)

session 27 DIABETES M .ppt
session 27 DIABETES M .pptsession 27 DIABETES M .ppt
session 27 DIABETES M .ppt
 
Diabetes - diagnosis,complication and monitoring by Dr Prabhash
Diabetes - diagnosis,complication and monitoring by Dr PrabhashDiabetes - diagnosis,complication and monitoring by Dr Prabhash
Diabetes - diagnosis,complication and monitoring by Dr Prabhash
 
Non-pharmacological Management of Diabetes Mellitus.pptx
Non-pharmacological Management of Diabetes Mellitus.pptxNon-pharmacological Management of Diabetes Mellitus.pptx
Non-pharmacological Management of Diabetes Mellitus.pptx
 
Diabetes pharmacotherapy(1)
Diabetes pharmacotherapy(1)Diabetes pharmacotherapy(1)
Diabetes pharmacotherapy(1)
 
Diabetes mellitus Biochemistry By Dr. Ashok KUmar Jeppu
Diabetes mellitus Biochemistry By Dr. Ashok KUmar JeppuDiabetes mellitus Biochemistry By Dr. Ashok KUmar Jeppu
Diabetes mellitus Biochemistry By Dr. Ashok KUmar Jeppu
 
Antidiabetic drugs.ppt
Antidiabetic drugs.pptAntidiabetic drugs.ppt
Antidiabetic drugs.ppt
 
Case study - DM 2, CKD 4
Case study - DM 2, CKD 4Case study - DM 2, CKD 4
Case study - DM 2, CKD 4
 
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase MethodDetermination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
Determination of Blood Glucose Using Glusose Oxidase-Peroxidase Method
 
Firoz ahmad m.sc.bio chemistry ppt daibetic nephropathy copy
Firoz ahmad m.sc.bio chemistry ppt  daibetic nephropathy   copyFiroz ahmad m.sc.bio chemistry ppt  daibetic nephropathy   copy
Firoz ahmad m.sc.bio chemistry ppt daibetic nephropathy copy
 
Care Conference Diabetes
Care Conference DiabetesCare Conference Diabetes
Care Conference Diabetes
 
Diabetes .pdf
Diabetes .pdfDiabetes .pdf
Diabetes .pdf
 
DIABETES MELLITUS.pptx
DIABETES  MELLITUS.pptxDIABETES  MELLITUS.pptx
DIABETES MELLITUS.pptx
 
Bmj.h5660.full
Bmj.h5660.fullBmj.h5660.full
Bmj.h5660.full
 
Bmj.h5660.full
Bmj.h5660.fullBmj.h5660.full
Bmj.h5660.full
 
Bmj.h5660.full
Bmj.h5660.fullBmj.h5660.full
Bmj.h5660.full
 
DKA clinical review
DKA clinical reviewDKA clinical review
DKA clinical review
 
DIABETES MELLITUS by dr aftab ahmed
DIABETES  MELLITUS by dr aftab ahmedDIABETES  MELLITUS by dr aftab ahmed
DIABETES MELLITUS by dr aftab ahmed
 
Diabetes melitus by dr aftab ahmed
Diabetes melitus by dr aftab ahmedDiabetes melitus by dr aftab ahmed
Diabetes melitus by dr aftab ahmed
 
diabetes mellitus om verma.pdf
diabetes mellitus om verma.pdfdiabetes mellitus om verma.pdf
diabetes mellitus om verma.pdf
 
METABOLIC SYNDROME.pptx
METABOLIC SYNDROME.pptxMETABOLIC SYNDROME.pptx
METABOLIC SYNDROME.pptx
 

More from bwalyakangwa582 (6)

13. VASODIL_ISCHEMIC HEART DISEASE_095100 (1).pptx
13. VASODIL_ISCHEMIC HEART DISEASE_095100 (1).pptx13. VASODIL_ISCHEMIC HEART DISEASE_095100 (1).pptx
13. VASODIL_ISCHEMIC HEART DISEASE_095100 (1).pptx
 
4-Oxytocics& tocolytics.labour inducers and inhibitors
4-Oxytocics& tocolytics.labour inducers and inhibitors4-Oxytocics& tocolytics.labour inducers and inhibitors
4-Oxytocics& tocolytics.labour inducers and inhibitors
 
endocrinology test.the hypothalamus controls the endocrine system
endocrinology test.the hypothalamus controls the endocrine systemendocrinology test.the hypothalamus controls the endocrine system
endocrinology test.the hypothalamus controls the endocrine system
 
L4-Pharmacology of local anesthesia.esters and amides
L4-Pharmacology of local anesthesia.esters and amidesL4-Pharmacology of local anesthesia.esters and amides
L4-Pharmacology of local anesthesia.esters and amides
 
8. Endocrine lecture eight (1) (1).pptx endocrinologist
8. Endocrine lecture eight (1) (1).pptx endocrinologist8. Endocrine lecture eight (1) (1).pptx endocrinologist
8. Endocrine lecture eight (1) (1).pptx endocrinologist
 
1. Respiratory system of both the upper and lower respiratory tract
1. Respiratory system of both the upper and lower respiratory tract1. Respiratory system of both the upper and lower respiratory tract
1. Respiratory system of both the upper and lower respiratory tract
 

Recently uploaded

SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
Peter Brusilovsky
 
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MysoreMuleSoftMeetup
 
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes GuàrdiaPersonalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
EADTU
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
EADTU
 

Recently uploaded (20)

Introduction to TechSoup’s Digital Marketing Services and Use Cases
Introduction to TechSoup’s Digital Marketing  Services and Use CasesIntroduction to TechSoup’s Digital Marketing  Services and Use Cases
Introduction to TechSoup’s Digital Marketing Services and Use Cases
 
OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...OS-operating systems- ch05 (CPU Scheduling) ...
OS-operating systems- ch05 (CPU Scheduling) ...
 
21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx21st_Century_Skills_Framework_Final_Presentation_2.pptx
21st_Century_Skills_Framework_Final_Presentation_2.pptx
 
SPLICE Working Group: Reusable Code Examples
SPLICE Working Group:Reusable Code ExamplesSPLICE Working Group:Reusable Code Examples
SPLICE Working Group: Reusable Code Examples
 
dusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learningdusjagr & nano talk on open tools for agriculture research and learning
dusjagr & nano talk on open tools for agriculture research and learning
 
Ernest Hemingway's For Whom the Bell Tolls
Ernest Hemingway's For Whom the Bell TollsErnest Hemingway's For Whom the Bell Tolls
Ernest Hemingway's For Whom the Bell Tolls
 
How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17How to Manage Call for Tendor in Odoo 17
How to Manage Call for Tendor in Odoo 17
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
MuleSoft Integration with AWS Textract | Calling AWS Textract API |AWS - Clou...
 
Observing-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptxObserving-Correct-Grammar-in-Making-Definitions.pptx
Observing-Correct-Grammar-in-Making-Definitions.pptx
 
AIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.pptAIM of Education-Teachers Training-2024.ppt
AIM of Education-Teachers Training-2024.ppt
 
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes GuàrdiaPersonalisation of Education by AI and Big Data - Lourdes Guàrdia
Personalisation of Education by AI and Big Data - Lourdes Guàrdia
 
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
Transparency, Recognition and the role of eSealing - Ildiko Mazar and Koen No...
 
Andreas Schleicher presents at the launch of What does child empowerment mean...
Andreas Schleicher presents at the launch of What does child empowerment mean...Andreas Schleicher presents at the launch of What does child empowerment mean...
Andreas Schleicher presents at the launch of What does child empowerment mean...
 
Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17Model Attribute _rec_name in the Odoo 17
Model Attribute _rec_name in the Odoo 17
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
PANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptxPANDITA RAMABAI- Indian political thought GENDER.pptx
PANDITA RAMABAI- Indian political thought GENDER.pptx
 
diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....diagnosting testing bsc 2nd sem.pptx....
diagnosting testing bsc 2nd sem.pptx....
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 

Diabetes mellitus both type 1 and 2 it's causes

  • 1. Integration of Metabolism Diabetes mellitus Mulungushi University School of Medicine and Health Sciences Bachelor of Science in program Biochemistry BMB 230 1 25-Jan-22 Mulungushi University School of Medicine and Health Sciences Dr. Masenga SK
  • 2. To cover •Metabolic effects of insulin and glucagon •The feed/fast cycle •Diabetes mellitus •The Biochemistry of Diabetes Mellitus •Forms of diabetes. •Molecular aspects of glucose transport. •Principles of treatment •Obesity 2 25-Jan-22 Mulungushi University School of Medicine and Health Sciences
  • 3. Principals • An adult human weighing 70 kg requires about 10–12 MJ (2400–2900 kcal) from metabolic fuels each day. • This requirement is met from • carbohydrates (40–60%), • lipids (mainly triacylglycerol, 30–40%), • protein (10–15%), • depending on whether the subject is in the fed or starving state and on the intensity of physical work. • When intake of fuels is consistently greater than energy expenditure → storage fat → obesity • When intake of fuels is consistently lesser than energy expenditure → high turnover → emaciation and death. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 3
  • 4. Integrated metabolism • Fed state: Glucose available → fuel for tissues • Starvation : glucose spared for use by the CNS (which is largely dependent on glucose) and the erythrocytes (which are wholly reliant on glucose) • Other tissues can utilize alternative fuels such as fatty acids and ketone bodies • As glycogen reserves become depleted, so amino acids arising from protein turnover and glycerol arising from lipolysis are used for gluconeogenesis. • Insulin and Glucagon regulate 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 4
  • 5. Glucagon and Insulin 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 5
  • 6. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 6
  • 7. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 7
  • 8. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 8
  • 9. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 9
  • 10. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 10
  • 11. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 11
  • 12. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 12 DIABETES MELLITUS
  • 13. DIABETES MELLITUS •Definition •Is actually a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion1, insulin action2, or both3. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 13
  • 14. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 14 Diabetes Mellitus classification
  • 15. •Therefore, the ADA/World Health Organization (WHO) guidelines recommend the following categories of diabetes: •Type 1 diabetes •Type 2 diabetes •Other specific types of diabetes; MODY(Maturity onset diabetes of the young) •Gestational diabetes mellitus (GDM) 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 15
  • 16. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 16 Classical symptoms
  • 17. Classical Signs and symptoms: •Polydipsia (Excessive Thirst) •Polyphagia (Increased Food Intake) •Polyuria (Excessive Urine Production) •Rapid Weight Loss** •Xerostomia (Dry Mouth) •Hyperventilation 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 17
  • 18. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 18 Pathophysiology Clue to understanding the classical features
  • 19. Type 1 diabetes •result of cellular-mediated autoimmune destruction of the cells of the pancreas, causing an absolute deficiency of insulin secretion. •constitutes only 10% to 20% of all cases of diabetes and •This disease is usually initiated by an environmental factor or infection (usually a virus) in individuals With a genetic predisposition commonly occurs in childhood and adolescence. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 19
  • 20. •Characterized by : •abrupt onset, insulin dependence, hyperglycaemia, hyperosmolarity, low pH(acidosis), ketonuria and ketonemia •85% to 90% of individuals with fasting hyperglycemia have 1 or more of these markers: 1. Islet cell autoantibodies, 2. Insulin autoantibodies, 3. glutamic acid decarboxylase autoantibodies, 4. tyrosine phosphatase IA-2 and IA-2B autoantibodies. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 20
  • 21. Antibodies in T1DM 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 21 •Glutamic acid decarboxylase 65 (GAD) •Protein tyrosine phosphatase islet antigen-2 (IA2) •Insulin. •Zinc transporter 8 (ZnT8)
  • 22. •Rationale For Diabetic Keto Acidosis •In type 1, there is an absence of insulin with an excess of glucagon. This permits gluconeogenesis and lipolysis to occur. •Patient’s lab profile presents with ketoacidosis tend to reflect dehydration, electrolyte disturbances and acidosis. •Acetoacetate, ᵝ-hydroxybutyrate and acetone are produced from the oxidation of fatty acids. • ketone bodies contribute to the acidosis. •Lactate, fatty acids, and other organic acids can also contribute to a lesser degree. complications 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 22
  • 23. •Bicarbonate and total carbon dioxide are usually decreased due to Kussmaul respiration (deep respirations). This is a compensatory mechanism to blow off carbon dioxide and remove hydrogen ions in the process. •The anion gap in this acidosis can exceed 16 mmol/L. Serum osmolarity is high as a result of hyperglycemia; •sodium concentrations tend to be lower (hyponatremia) due in part to losses (polyuria) and in part to a shift of water from cells because of the hyperglycemia. •Grossly elevated triglycerides will displace plasma volume and give the appearance of decreased electrolytes 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 23
  • 24.
  • 25. Type 1 Diabetes Mellitus •The individual will be hyperglycemic, which can be severe. • Glucosuria can also occur after the renal tubular transporter system for glucose becomes saturated. (at plasma glucose concentration ≥180 mg/dL (10mmol/l) in an individual with normal renal function and urine output ). • As hepatic glucose overproduction continues, the plasma glucose concentration reaches a plateau around 300 to 500 mg/dL (17–28 mmol/L). Provided renal output is maintained, glucose excretion will match the overproduction , causing the plateau. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 25
  • 26. •Hyperkalemia is almost always present as a result of the displacement of potassium from cells in acidosis. This is somewhat misleading because the patient’s total body potassium is usually decreased. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 26
  • 27. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 27
  • 28. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 28 Type 2 Diabetes Mellitus Clinical Biochemistry
  • 29. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 29
  • 30. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 30 Pathophysiology Clue to understanding the classical features
  • 31.
  • 32.
  • 33. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 33
  • 34. Insulin resistance •Defined as the failure of target tissue to respond normally to insulin •Leads to : • decreased uptake of glucose in muscle • Reduced glycolysis • Fatty acid oxidation in the liver • Inability to suppress hepatic gluconeogenesis • FATTY ACID EFFLUX out of adipose tissue due to hormone sensitive lipoprotein lipase 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 34
  • 35. ß-cell dysfunction •Due to prolonged insulin resistance & eventually hyperglycermia. Molecular mechanisms underlying ß-cell dysfunction in type 2 diabetes are multifactorial & overlap in many instances with those implicated in insulin resistance. •hence the excess NEFA & attenuated(reduced) insulin signaling (“lipotoxicity”) predispose to both insulin resistance & ß-cell failure. •Amyloid replacement of islets is a characteristic finding in individuals with long standing type 2 diabetes & is present in more than 90% of diabetic islets examined. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 35
  • 36. •In type 2, insulin is present, as is (at times) hyperinsulinemia; therefore, glucagon is attenuated (lowered/reduced) → Weight gain (lipogenesis) •Fatty acid oxidation is inhibited in type 2. This causes fatty acids to be incorporated into triglycerides for release as very low density lipoproteins (VLDL). •This might predispose a patient to acute pancreatitis, development of eruptive xanthomata (cholesterol deposits) and atherosclerosis. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 36
  • 37. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 37 Pathophysiology Underlying Long term complications
  • 38. PATHOPHYSIOLOGY CHAGES THAT EXPLAIN THE LONG TERM COMPLICATIONS OF DIABETES. •The molecular pathogenesis of chronic diabetes complications- 1. Excessive reactive oxygen species production 2. Formation of advanced glycosylation end (AGE) products 3. Sorbitol production via the aldose reductase pathway 4. Protein kinase c activation Mnemonic = RASP 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 38
  • 39. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 39 Long term Complications of T2DM
  • 40. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 40 Macrovascular complications (coronary artery disease, peripheral arterial disease, and stroke) Microvascular complications (diabetic nephropathy, neuropat hy, and retinopathy)
  • 41. Short-term complications include: •Hypoglycaemia •Diabetic ketoacidosis (DKA), •Hyperosmolar hyperglycaemic state (HHS). 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 41
  • 42. Infections • Leukocyte function is compromised and immune responses are blunted. hyperglycaemia effects in infections: • Chemo taxis reduced • Inhibits leukocyte rolling & adherence & phagocytosis • reduces macrophage activation • Reduces activation of the complement activation (C5a) therefore reducing the Mac pathway (membrane attack complex) that lyses bacteria • Urinary tract infections are problematic • Diabetes may develop fatal fungal infection - mucormycosis 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 42
  • 43. Chemotaxis 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 43
  • 44. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 44 Diagnosis
  • 45. LABORATORY FINDINGS IN HYPERGLYCEMIA 1. Increased glucose in plasma and urine 2. Increased urine specific gravity 3. Increased serum and urine osmolality 4. Ketones in serum and urine (ketonemia and ketonuria) 5. Decreased blood and urine pH (acidosis) 6. Electrolyte imbalance 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 45
  • 46. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 46
  • 47. Fasting blood glucose • The FPG test is used to detect diabetes and prediabetes • Fasting plasma glucose = 7.0 mmol/L • Impaired fasting glucose = 5.6 to 6.9 mmol/L • most common test used for diagnosing diabetes • more convenient and less expensive. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 47
  • 48. Random blood glucose • Symptoms of diabetes (polyuria, polydipsia, unexplained weight loss, fatigue, blurred vision, polypagia, and sores that do not heal). • Random blood glucose concentration >11.1 mmol/L . • A repeat test can be done for confirmation 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 48
  • 49. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 49
  • 50. Oral Glucose Tolerance Test • The OGTT can be used to diagnose diabetes, prediabetes, and gestational diabetes. • 2-hr postload glucose >11.1 mmol/L during an oral glucose tolerance test (OGTT) is diabetes • identifies more patients as having diabetes than the fasting plasma glucose test, • greater expense and complexity and lower reproducibility • Rarely used 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 50
  • 51. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 51
  • 52. Glycated Hemoglobin - HbA1C • Reflects the average blood glucose levels over the past 3 months and does not show daily fluctuations. • Reported as a percentage with threshold level of 6.5%. • It does not require fasting and can be performed at any time of the day. • Hemoglobinopathies and conditions of altered red-cell turnover can give unreliable results • Racial and ethnic differences in glycated hemoglobin levels have been reported for given ambient glucose levels. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 52
  • 53. Criteria for the Testing and Diagnosis of Gestational Diabetes Mellitus • Only high-risk patients should be screened for GDM.: • age older than 25 years, • overweight, strong family history of diabetes, • history of abnormal glucose metabolism, • history of a poor obstetric outcome, • presence of glycosuria, • diagnosis of PCOS, or a member of an ethnic/racial group with a high prevalence of diabetes (e.g., Hispanic American, Native American, Asian American, African American, Pacific Islander). 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 53
  • 54. Criteria for the Testing and Diagnosis of Gestational Diabetes Mellitus • The first step in screening for gestational diabetes should be performance of fasting plasma glucose (as indicated earlier) with a confirmation test if needed for diagnosis. • In the absence of a positive confirmation, evaluation for gestational diabetes in women with average or high-risk characteristics should follow one of two approaches.: • The one-step approach would be the im-mediate performance of a 3-hour OGTT without prior screening. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 54
  • 55. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 55 Risk factors
  • 56. Risk factors • BMI • Family history • Age • Physical activity • Sedentary lifestyle • Diet • Existing NCDs • Drugs 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 56
  • 57. 25-Jan-22 Mulungushi University School of Medicine and Health Sciences 57
  • 58. reference • Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Weil PA; Harper’s illustrated Biochemistry, 28th edition; http://www.accessmedicine.com 58 25-Jan-22 Mulungushi University School of Medicine and Health Sciences